Lataa...
In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates
CD44 promotes metastasis, chemoresistance, and stemness in different types of cancer and is a target for the development of new anti-cancer therapies. All CD44 isoforms share a common N-terminal domain that binds to hyaluronic acid (HA). Herein, we used a computational approach to design new potenti...
Tallennettuna:
| Julkaisussa: | Molecules |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8037692/ https://ncbi.nlm.nih.gov/pubmed/33810348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/molecules26071877 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|